Viewing Page 2 of 20 | Showing Results 11 - 20 of 198
The goal of the Global cVAD Registry is to collect clinical and procedural data retrospectively from hospital medical records for patients who...
John L. Petersen II, MD
The EVOLVE Short DAPT Study is a prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk...
The HeartMate PHP System is a temporary (<6 hours) ventricular assist device indicated for use during high risk percutaneous coronary...
John L. Petersen II, MD
To examine the efficacy of targeting atrial fibrosis tissue during an ablation procedure treating persistent Atrial Fibrillation.
Darryl S. Wells, MD
Evaluating the safety and effectiveness of the Medtronic TAVR (Transcatheter Aortic Valve Replacement) System in patients with severe aortic...
Sameer Gafoor, MD and Eric Lehr, MD
The AmuletTM device will be evaluated for safety and efficacy by demonstrating its performance is non-inferior to the commercially available WATCHMAN® left atrial appendage closure device in patients with non-valvular atrial fibrillation. Patients who are eligible for the trial will be randomized to receive either the Amulet device or the WATCHMAN device and will be followed for 5 years after device implant.
Sameer Gafoor, MD
The purpose of this study is to determine if treatment with omecamtiv mecarbil/AMG 423 when added to standard of care is well tolerated and...
John L. Mignone, MD, PhD
The primary objective of this study is to demonstrate using polysomnography (PSG) that 10 mg lemborexant is superior to zolpidem tartrate extended...
Sarah Stolz, MD
To demonstrate safety and effectiveness of the Arctic Front Advance™ and Freezor MAX® Cardiac CryoAblation Catheters for the treatment of...
Darryl S. Wells, MD
The Chocolate Touch study is a randomized, multi-center, prospective, adaptive study, designed to show sufficient safety and effectiveness of the...
Paul P. Huang, MD
Viewing Page 2 of 20 | Showing Results 11 - 20 of 198